Welcome to Onchem (China) Co.,Ltd, and welcome to inquiry me about all our products, we will provice the 

competitive price for u. We are sincerely responsible for the "product quality" and "After Service"

(3) Application

    The main ingredient of NEUPRAMIR is pramiracetam, a pharmaceutical product with nootropic effects. Experimental

studies have proved it to be effective in improving memory and learning capacity.
 

    Pramiracetam is a nootropic drug derived from piracetam, and is more potent (i.e. lower dosage is used). It belongs to

the racetam family of nootropics.

   For the elderly attention and memory disorders, benign aging forgetfulness, Alzheimer's disease.
 

    Pramiracetam was developed based on Piracetam, and is 8-30 times stronger than Piracetam. It goes by the trade

name Neupramir or Pramistar.

    Pramiracetam (2-(2-oxopyrrolidin-1-yl)-N-[2-(diisopropylamino)ethyl]acetamid) is another nootropic that is derived

from piracetam, but is roughly 10 times more potent. It was originally developed by the American pharmaceutical

company Parke-David (now a division of Pfizer), which marketed under the name “Remen”. It has also been sold as CI-

879, Neupramir, Ectapram, and Pramistar, among others. Pramiracetam is currently produced in Italy, but U.S.-based

development has been discontinued.

    Pramiracetam is a wonderful mind boosting drug which has been found to enhance memory, sharpen intelligence and

boost mental energy for an overall energetic performance and vibrant mood. Belonging to the racetam class, this nootropic

medicine is much more powerful and potent than its predecessor piracetam not only inimproving memorybut in increasing

cognition and attentionas well.

    Since pramiracetamis known to enhance memory and is seven times stronger than previous nootropic drugs of the same

class, this brain boosting medicine proves to be an effective alazhiemer's disease treatment, treatment of memory loss, age

related memory decline, lack of concentration, parkinson's disease and other such mind related disorders and conditions.

Like the other racetam compounds, pramiracetam has been demonstrated to positively affect cognition. It has been

demonstrated to enhance learning and memory in animals; a 30-mg/kg dose enhanced rats’ ability to remember objects

that had been previously introduced into their cage. For comparison, a 400-mg/kg dose of piracetam was necessary to

elicit the same effect. Similar results have been shown in humans. A 10-month long study in men with brain injuries

revealed that 400 mg per day yielded cognitive improvements in just 1 month.

    Anecdotally, users report that pramiracetam enhance goal-directed and purposeful behavior, as well as better

concentration and retention.

(4) Factory Picture: